Fig 1.
Flow chart of participants through the study.
Table 1.
Demographic and clinical characteristics of study participants.
Values are mean ± SD.
Fig 2.
Comparison of serum prolactin levels between groups.
Data are expressed as means ± SD and were analyzed by repeated measures analysis of variance or Student's t-test. *P<0.001, Aripiprazole groupvs. control group for weeks 2–8;** P<0.001, vs. control.
Fig 3.
Comparisons of BMIs (A) and plasma LDL levels (B) between groups.
Data are expressed as means ± SD and were analyzed byStudent's t-test.*P<0.05, vs. control.
Table 2.
Changes in plasma glucose, Total cholesterol, Triglycerides,and High Density Lipoprotein after additional treatment aripiprazole.
Values are mean ± SD.
Fig 4.
Comparisons of PANSS total and subscale scores between groups.
Data are expressed as means ± SD and were analyzed byStudent's t-test. **P <0.01, vs. control.
Table 3.
Adverse events observed in the study (incidence ≥5%).